These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1784257

  • 1. Lysis of murine macrophages by lymphokine-activated killer-like cells induced by BCG in vitro.
    Chen MF, Suzuki H, Yano S.
    Microbiol Immunol; 1991; 35(7):557-67. PubMed ID: 1784257
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
    Suzuki H, Ikemoto M, Yokoyama A, Kamitani T, Yamashita N, Maruyama M, Yano S.
    Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
    [Abstract] [Full Text] [Related]

  • 3. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
    Chen MF, Suzuki H, Yano S.
    Anticancer Res; 1992 Jan; 12(2):451-6. PubMed ID: 1580562
    [Abstract] [Full Text] [Related]

  • 4. Systemic administration of IL-2 induces lymphokine-activated killer (LAK) cells capable of killing macrophages in various tissues.
    Kamitani T, Suzuki H, Yano S.
    Immunology; 1989 Dec; 68(4):520-5. PubMed ID: 2606510
    [Abstract] [Full Text] [Related]

  • 5. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, Jocham D, Flad HD, Böhle A.
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [Abstract] [Full Text] [Related]

  • 6. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA.
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [Abstract] [Full Text] [Related]

  • 7. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity.
    Tunru IS, Suzuki H, Yano S.
    Int J Cancer; 1991 Jun 19; 48(4):568-73. PubMed ID: 2045201
    [Abstract] [Full Text] [Related]

  • 8. Autocytotoxic activity of lymphokine-activated killer cells: characterization of effector cells and susceptible targets.
    Suzuki H, Ikemoto M, Kamitani T, Hoshino K, Yano S.
    Anticancer Res; 1989 Jun 19; 9(2):293-7. PubMed ID: 2568770
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT, Eisenthal A, Rosenberg SA.
    J Immunol; 1988 Jun 01; 140(11):4062-9. PubMed ID: 3259603
    [Abstract] [Full Text] [Related]

  • 10. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
    Ballas ZK, Rasmussen W.
    J Immunol; 1990 Jan 01; 144(1):386-95. PubMed ID: 2104892
    [Abstract] [Full Text] [Related]

  • 11. The specificity of lymphokine-activated killer (LAK) cells in vitro: fresh normal murine tissues are resistant to LAK-mediated lysis.
    Lefor AT, Rosenberg SA.
    J Surg Res; 1991 Jan 01; 50(1):15-23. PubMed ID: 1987427
    [Abstract] [Full Text] [Related]

  • 12. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans.
    Scaringi L, Cornacchione P, Rosati E, Boccanera M, Cassone A, Bistoni F, Marconi P.
    Cell Immunol; 1990 Sep 01; 129(2):271-87. PubMed ID: 2166624
    [Abstract] [Full Text] [Related]

  • 13. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L, Lemieux S.
    J Immunol; 1993 Dec 15; 151(12):6783-93. PubMed ID: 8258690
    [Abstract] [Full Text] [Related]

  • 14. Gelatin sponge model of effector recruitment: tumoricidal activity of adherent and non-adherent lymphokine-activated killer cells after culture in interleukin-2.
    Akporiaye ET, Barbieri CA, Stewart CC, Bender JG.
    J Leukoc Biol; 1991 Feb 15; 49(2):189-96. PubMed ID: 1991999
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ, Merchant RE, Hall RE.
    Immunology; 1989 Jan 15; 66(1):117-24. PubMed ID: 15493273
    [Abstract] [Full Text] [Related]

  • 16. Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes.
    Molloy A, Meyn PA, Smith KD, Kaplan G.
    J Exp Med; 1993 Jun 01; 177(6):1691-8. PubMed ID: 7684432
    [Abstract] [Full Text] [Related]

  • 17. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 18. A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells.
    Hoskin DW, Stankova J, Anderson SK, Roder JC.
    Int J Cancer; 1989 May 15; 43(5):940-8. PubMed ID: 2469657
    [Abstract] [Full Text] [Related]

  • 19. Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors.
    Sensi M, Grazioli L, Rodolfo M, Parmiani G.
    Cancer Immunol Immunother; 1990 May 15; 31(1):37-43. PubMed ID: 2306754
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity of cell surface structures involved in cytotoxicity mediated by lymphokine activated killer cells.
    Bean P, Agah R, Mazumder A.
    J Biol Response Mod; 1990 Feb 15; 9(1):92-7. PubMed ID: 2181073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.